|Articles|November 8, 2011
Pfizer Outlines its Supply Strategy
John Kelly, vice-president of strategy and transitioning sites for Pfizer Global Supply, discusses the company's manufacturing and supply strategy and network.
Advertisement
John Kelly,
vice-president, strategy and transitioning sites,
Pfizer Global Supply
John Kelly, vice-president of strategy and transitioning sites for Pfizer Global Supply, discusses the company's manufacturing and supply strategy and network with Patricia Van Arnum, senior editor of Pharmaceutical Technology (Posted November 2011).
Click
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Trends Transitioning from 2025 into 2026
2
Amgen Acquires UK Biotech Dark Blue Therapeutics
3
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 2: A Detailed Assessment for Specification Equivalence
4
Genetic Medicines Project Gets Funding from UKRI Innovate UK and Canadian NRC IRAP
5
